DE602005024036D1 - Umkehr-mizellen-zusammensetzung zur abgabe von metallkationen mit einem diglycerid und einem phytosterol und herstellungsverfahren - Google Patents

Umkehr-mizellen-zusammensetzung zur abgabe von metallkationen mit einem diglycerid und einem phytosterol und herstellungsverfahren

Info

Publication number
DE602005024036D1
DE602005024036D1 DE602005024036T DE602005024036T DE602005024036D1 DE 602005024036 D1 DE602005024036 D1 DE 602005024036D1 DE 602005024036 T DE602005024036 T DE 602005024036T DE 602005024036 T DE602005024036 T DE 602005024036T DE 602005024036 D1 DE602005024036 D1 DE 602005024036D1
Authority
DE
Germany
Prior art keywords
reverse
phytosterol
diglyceride
micro
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005024036T
Other languages
English (en)
Inventor
Jean-Claude Maurel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medesis Pharma SA
Original Assignee
Medesis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medesis Pharma SA filed Critical Medesis Pharma SA
Publication of DE602005024036D1 publication Critical patent/DE602005024036D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Polymers & Plastics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • AIDS & HIV (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Psychology (AREA)
DE602005024036T 2004-11-02 2005-11-02 Umkehr-mizellen-zusammensetzung zur abgabe von metallkationen mit einem diglycerid und einem phytosterol und herstellungsverfahren Active DE602005024036D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04025987A EP1652512A1 (de) 2004-11-02 2004-11-02 Umkehrmizellen-Zusammensetzung zur Verabreichung von Metallkationen enthaltend einen Diglycerid und einen Phytosterol und Verfahren zur Herstellung
PCT/IB2005/003605 WO2006048773A1 (en) 2004-11-02 2005-11-02 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation

Publications (1)

Publication Number Publication Date
DE602005024036D1 true DE602005024036D1 (de) 2010-11-18

Family

ID=34927200

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005024036T Active DE602005024036D1 (de) 2004-11-02 2005-11-02 Umkehr-mizellen-zusammensetzung zur abgabe von metallkationen mit einem diglycerid und einem phytosterol und herstellungsverfahren

Country Status (17)

Country Link
US (1) US9173838B2 (de)
EP (2) EP1652512A1 (de)
JP (1) JP4975631B2 (de)
CN (1) CN101102751B (de)
AT (1) ATE483454T1 (de)
AU (1) AU2005300253B2 (de)
CA (1) CA2584684C (de)
DE (1) DE602005024036D1 (de)
DK (1) DK1807048T3 (de)
EA (1) EA012210B1 (de)
ES (1) ES2353804T3 (de)
HK (1) HK1108368A1 (de)
IL (1) IL182756A (de)
PL (1) PL1807048T3 (de)
PT (1) PT1807048E (de)
WO (1) WO2006048773A1 (de)
ZA (1) ZA200704286B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1652513A1 (de) * 2004-11-02 2006-05-03 Denderah Pharm Sa Reverse Mizellen auf der Basis von Sterolen und Acylglycerolen und ihre therapeutischen Verwendungen
WO2011117333A2 (en) 2010-03-24 2011-09-29 Medesis Pharma Reverse micelle system comprising metal ions and use thereof
BRPI1000970A2 (pt) * 2010-04-07 2011-11-29 Fundacao Arnaldo Vieira De Carvalho composição farmacêutica para o tratamento da doença de alzheimer, processo para sua obtenção e uso
WO2012007387A1 (en) * 2010-07-13 2012-01-19 Medesis Pharma Low- dose lithium for the treatment of neurodegenerative disorders
EP3319588A1 (de) * 2015-07-09 2018-05-16 Medesis Pharma In-situ-herstellung von cyano-verbrückten metallnanopartikeln innerhalb eines biokompatiblen reversmizellaren systems
BR112021000121A2 (pt) * 2018-07-06 2021-04-06 Medesis Pharma Tratamento e prevenção de lesões devido a exposição à radiação

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252333A (en) * 1987-04-27 1993-10-12 Scotia Holdings Plc Lithium salt-containing pharmaceutical compositions
FR2658816A1 (fr) * 1990-02-27 1991-08-30 Adir Nouveaux sels de metaux alcalinoterreux d'oxa-polyacides leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2729957B1 (fr) 1995-01-31 1997-12-05 Maurel Sante Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant.
FR2750606B1 (fr) * 1996-07-03 1999-01-29 Maurel Sante Complexes organometalliques a base de sitosterols et de diglycerides et compositions pharmaceutiques en contenant
JPH119988A (ja) * 1997-06-26 1999-01-19 Advanced Sukin Res Kenkyusho:Kk 油中水型マイクロエマルション
JPH1129464A (ja) * 1997-07-07 1999-02-02 Advanced Sukin Res Kenkyusho:Kk コレステロールを添加する油中水型マイクロエマルション
WO2000057721A2 (en) * 1999-03-26 2000-10-05 Akesis Pharmaceuticals, Inc. Edible solids for treatment of glucose metabolism disorders
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
US6365176B1 (en) * 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
SK9472003A3 (en) * 2001-01-25 2003-12-02 Unilever Nv An edible water-in-oil microemulsion, process for the preparation thereof, a food product containing same and use such a microemulsion
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
EP1452175A1 (de) * 2003-02-28 2004-09-01 Medesis Pharma S.A. Organometallische Komplexe entahltend Mangan, pharmazeutische Formulierungen und Diätetika
CN1457773A (zh) * 2003-06-02 2003-11-26 乐益 治疗糖尿病的双胍钒络合物颗粒剂和/或胶囊剂及其用途
EP1652513A1 (de) * 2004-11-02 2006-05-03 Denderah Pharm Sa Reverse Mizellen auf der Basis von Sterolen und Acylglycerolen und ihre therapeutischen Verwendungen

Also Published As

Publication number Publication date
EP1652512A1 (de) 2006-05-03
IL182756A0 (en) 2007-07-24
JP2008519026A (ja) 2008-06-05
PL1807048T3 (pl) 2011-03-31
CN101102751B (zh) 2011-08-24
US9173838B2 (en) 2015-11-03
ZA200704286B (en) 2008-09-25
JP4975631B2 (ja) 2012-07-11
PT1807048E (pt) 2010-11-29
ES2353804T3 (es) 2011-03-07
EA200700994A1 (ru) 2007-10-26
EP1807048B1 (de) 2010-10-06
AU2005300253B2 (en) 2010-09-09
HK1108368A1 (en) 2008-05-09
US20090087477A1 (en) 2009-04-02
WO2006048773A1 (en) 2006-05-11
IL182756A (en) 2011-02-28
CN101102751A (zh) 2008-01-09
AU2005300253A1 (en) 2006-05-11
ATE483454T1 (de) 2010-10-15
EA012210B1 (ru) 2009-08-28
CA2584684A1 (en) 2006-05-11
EP1807048A1 (de) 2007-07-18
CA2584684C (en) 2013-07-02
DK1807048T3 (da) 2011-01-10

Similar Documents

Publication Publication Date Title
DE602005024036D1 (de) Umkehr-mizellen-zusammensetzung zur abgabe von metallkationen mit einem diglycerid und einem phytosterol und herstellungsverfahren
DE60216108D1 (de) Vorrichtung zur herstellung von verbundstrukturen und verfahren zu deren herstellung
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
DE60233976D1 (de) Vorrichtung und Methode zur Herstellung von Barriereschichten für Metalle sowie Vorrichtung und Methode zur Herstellung von Metallschichten
WO2006093972A3 (en) Particles
DE602005021158D1 (de) L-Zystein-produzierender Mikroorganismus und Verfahren zur Produktion von L-Zystein
DE60203884D1 (de) Verfahren und elektrolysezelle zur herstellung von metall
DE50200543D1 (de) Verfahren zur Behandlung und Zubereitung von Nahrungsmitteln in einem Gargerät, Bedienfeld für ein Gargerät sowie Gargerät mit Bedienfeld
ATE508776T1 (de) Elemente zur trennung von substanzen durch verteilung zwischen einer stationären und einer mobilen phase und verfahren zur herstellung einer trennvorrichtung
DE602006000199D1 (de) Turbolader mit verstellbarem Einlass und Verfahren zur Herstellung von Teilen dessen Verstellungsmechanismus
ATE429156T1 (de) Nahrungsergänzung zur behandlung von makula degeneration
ATE486841T1 (de) Verfahren zur herstellung von pregabalin und salzen daraus
PL375917A1 (en) Method for producing coated pharmaceuticals and food supplements with concentration gradients in the coating thereof
ATE362707T1 (de) Verfahren zur herstellung von milchpulver und konzentrierten milchprodukten
DE602004006944D1 (de) Komposit-Teilchen, welche aufeinanderfolgende Änderungen in Lebensmitteln bewirken, und deren Herstellungsverfahren
DE502004005547D1 (de) Vorrichtung zur Wärmebehandlung von Substanzen, insbesondere Nahrungsmitteln
ATE401903T1 (de) Verbessertes verfahren zur herstellung von ginkgoextrakten mit geringem gehalt an 4'-o- methylpyridoxin und/oder biflavonen
DE50103807D1 (de) Anker mit blechlaminaten und verfahren zur herstellung dieses ankers
ATE329930T1 (de) Fsh-zusammensetzungen mit hohem sialylierungsgrad und deren verwendung zur herstellung von arzneimitteln
ATE336167T1 (de) Materialien zur freisetzung von flüchtigen stoffen und methoden zu deren herstellung
DE60321751D1 (de) Polyurethan-Harnstoffe, nützlich zur Herstellung von Spandex und ein Verfahren zu ihrer Herstellung
WO2007012807A3 (en) Dna structures
DE602005003678D1 (de) Gemischtes olanzapinsolvat, verfahren zu dessen herstellung und verfahren zur herstellung von olanzapin-form i daraus
ATE265810T1 (de) Nahrungsmittel oder nahrungsergänzungsmittel mit hohem energiewert, verfahren zu dessen herstellung und seine verwendungen
DE60210184D1 (de) L-cystein herstellendes Bakterium und Verfahren zur Herstellung von L-cystein